Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 35 544 | déclaré | 04 mars 2026 | tx 160+130 015−49 426 |
| Lexeo Therapeutics, Inc. | 14 583 | déclaré | 26 juin 2025 | tx 2+50 583 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 289 | 321.82 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 215 | 320.81 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 102 | 320.01 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 767 | 323.84 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 272 | 324.88 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 350 | 323.01 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 106 | 319.03 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 208 | 325.67 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 100 | 328.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 329 | 327.67 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 392 | 326.81 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 258 | 325.63 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 90 | 324.65 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 37 | 332.64 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4 769 | 0.00 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 94 | 331.93 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 81 | 330.85 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 170 | 329.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 47 | 323.62 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 10 480 | 0.00 USD | deriv |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1 666 | 0.00 USD | |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1 666 | 0.00 USD | deriv |
| 13 févr. 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1 959 | 310.08 USD | |
| 12 févr. 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | |
| 11 janv. 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 3 800 | 0.00 USD |